Biomarkers

A biomarker can be anything that can be accurately measured as an indicator of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug intervention.  Biomarkers are usually in molecular form. Biomarkers take part in various purposes, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety evaluation. The   Biomarkers are exclusively being developed and validated to be used in drug development, and used to support approval of drug products.
Biomarkers are mainly classified into Protein biomarkers, Nucleic acid based biomarkers, Lipid biomarkers and Small molecule biomarkers. Almost every pharmaceutical company has been developing biomarker programs. There has been a rapid increase in the number of Biomarkers Congress used in drug delivery over the last decade.

 

  • Protein Biomarkers
  • Nucleic acid biomarkers
  • Lipid biomarkers
  • Small molecule biomarkers

Related Conference of Biomarkers

April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in